Lupus Capital PLC
19 April 2007
Not for release, publication or distribution into the United States, Canada,
Japan or Australia
Lupus Capital plc ('Lupus Capital' or 'the Company')
Results of the Extraordinary General Meeting
On 19 March 2007 Lupus Capital announced the proposed acquisition of the
Security Systems Division of The Laird Group PLC ('Laird Security Systems').
Subsequently, on 26 March 2007 the Company announced the terms of the Placing
and Open Offer of 755,555,556 New Ordinary Shares at an issue price of 18 pence
per share to finance part of the Acquisition.
At the Extraordinary General Meeting ('EGM') of the Company held today, all of
the resolutions set out in the notice of EGM and the Prospectus dated 26 March
2007 were duly passed.
The Company also confirms that the waiting period under the US Hart-Scott-Rodino
Anti-trust Improvements Act of 1976 has expired and that the approval for the
sale of Laird Security Systems by shareholders of The Laird Group PLC occurred
on 12 April 2007.
Accordingly, following the satisfaction of the remaining conditions of the
Acquisition Agreement as set out in the Prospectus, it is expected that, with
effect from 8 a.m. on 27 April 2006, the Company's current listing on AIM will
be cancelled and simultaneously the Enlarged Group will be admitted to trading
on AIM.
Terms used in this announcement shall have the same meanings as set out in the
Prospectus dated 26 March 2007.
Enquiries:
Equity Development
Alan Frame 020 7405 7777
HSBC Bank plc:
Investment Banking
Rupert Faure Walker 020 7992 2101
James Pincus 020 7992 2121
Equity Capital Markets
Nick Donald 020 7991 1504
James Taylor 020 7992 2179
Further information on Lupus Capital is available on the company's website
(www.lupuscapital.co.uk)
Not for release, publication or distribution into the United States, Canada,
Japan or Australia
HSBC is acting exclusively for Lupus Capital and no one else in relation to the
Acquisition and Placing and Open Offer referred to in this announcement and will
not be responsible to anyone other than Lupus Capital for providing the
protections afforded to their clients or for providing advice in relation to the
Acquisition and Placing and Open Offer or any other matter referred to in this
announcement.
This announcement and the information contained herein are not an offer for sale
of securities in or into the United States, Australia, Canada or Japan or in any
other jurisdiction. The Ordinary Shares, nor any rights to subscribe for such
Ordinary Shares, have not been and are not being registered under the United
State Securities Act of 1933, as amended (the Securities Act) and may not be
offered or sold in the United States or to or for the account or benefit of US
persons (as such terms are defined in Regulation S under such Act) absent
registration under, or an exemption from registration under, or in a transaction
not subject to the requirements of, the Securities Act. There will be no public
offer of securities in the United States.
This announcement and the information contained herein does not constitute an
offer to sell, exchange or transfer any securities of Lupus Capital and is not
soliciting an offer to purchase, exchange or transfer such securities in any
jurisdiction where the offer, sale, exchange or transfer is not permitted or to
any person or entity to whom it is unlawful to make that offer, sale, exchange
or transfer.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.